BridgeMD
New treatment option for Healthy Volunteer EGEA4 Cohort
Official title EGEA4 THE 30 YEAR FOLLOW UP OF THE EGEA STUDY
ClinicalTrials.gov ID: NCT06334705
What this study is testing
- What it's testing
- Cardiovascular (CV) diseases affect 523 million people worldwide, and are the leading cause of death, accounting for over 18 million deaths (around 30% of all deaths) every year. CV diseases account for around 45% of all deaths in Europe, or around 140,000 deaths a year in France.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Have participated in at least one of the previous EGEA surveys;
- to be affiliated to a social security scheme or to be a beneficiary of such a scheme.
You likely can't join if
- Person deprived of liberty by judicial or administrative decision;
- Person subject to a legal protection measure (safeguard of justice, curatorship or guardianship).
The study team makes the final eligibility decision.
Where it's taking place
- Grenoble, France
- Lyon, France
- Marseille, France
- Montpellier, France
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Grenoble, France; Lyon, France; Marseille, France; Montpellier, France; Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.